| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7981439 | ZYLA | Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof |
Nov, 2023
(4 months ago) | |
| US7510726 | ZYLA | Methods and compositions for deterring abuse of opioid containing dosage forms |
Nov, 2023
(4 months ago) | |
| US8637540 | ZYLA | Compositions for deterring abuse of opioid containing dosage forms |
Nov, 2023
(4 months ago) | |
| US8409616 | ZYLA | Extended release opioid abuse deterrent compositions and methods of making same |
Nov, 2023
(4 months ago) | |
| US9492443 | ZYLA | Abuse deterrent compositions and methods of making same |
May, 2024
(29 days from now) | |
| US7201920 | ZYLA | Methods and compositions for deterring abuse of opioid containing dosage forms |
Mar, 2025
(10 months from now) | |
Oxaydo is owned by Zyla.
Oxaydo contains Oxycodone Hydrochloride.
Oxaydo has a total of 6 drug patents out of which 4 drug patents have expired.
Expired drug patents of Oxaydo are:
- US7981439
- US7510726
- US8637540
- US8409616
Oxaydo was authorised for market use on 17 June, 2011.
Oxaydo is available in tablet;oral dosage forms.
The generics of Oxaydo are possible to be released after 16 March, 2025.
Drugs and Companies using
OXYCODONE HYDROCHLORIDE ingredient
Market Authorisation Date:
17 June, 2011Treatment:
NADosage:
TABLET;ORAL
How can I launch a generic of OXAYDO before its drug patent expiration?
More Information on Dosage
OXAYDO family patents
